Biogen Inc.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spina…
Drug Manufacturers - General
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Biogen Inc. (BIIB) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—General Average | - - | - - | - - | 99,491.87 | 5,998.47 | 890.20 | 3,327.15 | 87.69 | 0.01 | -5.3701 | 0.63 | 0.5559 | 0.0014 | 0.00 | 0.08 | 2.5260 | - - | ||
| Maximum | - - | - - | - - | 711,911.00 | 13,765.00 | 2,242.00 | 12,553.00 | 1,294.00 | 0.04 | 76.3636 | 2.49 | 0.8250 | 0.2558 | 0.04 | 0.53 | 21.1421 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 77.00 | -82.00 | -1,283.00 | -2,626.00 | 0.00 | -311.9276 | -0.15 | 0.0683 | -0.9021 | -0.08 | -0.04 | 0.0000 | - - | ||
| AbbVie Inc. ABBV | 171.73 | 3.97 2.37% | 5,621 vs. 5,440 | 303,470.00 | 12,310.00 | 1,369.00 | 3,847.00 | -2,384.00 | 0.7700 | 58.3938 | 0.0087 | 0.6684 | 0.1112 | 0.1710 | 0.0092 | 0.7229 | 1,767.00 | ||
| GSK plc GLAXF | 16.94 | 0.00 0.00% | 0 vs. 4 | 69,098.00 | 7,363.00 | 1,046.00 | 376.00 | 7,935.00 | 0.2600 | 15.5725 | 0.0087 | 0.7369 | 0.1421 | 0.0756 | 0.0179 | 0.5737 | 4,078.00 | ||
| Gilead Sciences, Inc. GILD | 89.76 | 1.13 1.28% | 3,896 vs. 6,733 | 111,865.00 | 6,686.00 | -4,170.00 | 2,114.00 | 10,656.00 | -3.3400 | -5.4485 | 0.0109 | 0.7679 | -0.6237 | -0.2378 | -0.0741 | 0.8243 | 1,246.00 | ||
| Bristol-Myers Squibb Company BMY | 58.23 | 0.35 0.60% | 6,131 vs. 11,052 | 118,100.00 | 11,865.00 | -11,911.00 | 2,550.00 | 15,640.00 | -5.8900 | -2.2500 | 0.0113 | 0.7529 | -1.0039 | -0.7223 | -0.1203 | 0.9190 | 2,028.00 | ||
| Pfizer Inc. PFE | 25.13 | 0.19 0.76% | 44,697 vs. 36,462 | 142,411.00 | 14,879.00 | 3,115.00 | 387.00 | 121,318.00 | 0.5500 | 12.5852 | 0.0151 | 0.7056 | 0.2094 | 0.0338 | 0.0141 | 0.5659 | 5,666.00 | ||
| Amgen Inc. AMGN | 289.90 | 2.03 0.71% | 3,283 vs. 2,169 | 155,830.00 | 7,396.00 | -113.00 | 459.00 | -27,870.00 | -0.2100 | -335.6404 | 0.0080 | 0.5673 | -0.0153 | -0.0225 | -0.0012 | 0.8362 | 537.00 | ||
| Merck & Co., Inc. MRK | 99.86 | 2.42 2.48% | 12,019 vs. 9,695 | 252,609.00 | 15,809.00 | 4,762.00 | 2,229.00 | 56,697.00 | 1.8800 | 17.4190 | 0.0059 | 0.7511 | 0.3012 | 0.1180 | 0.0450 | 0.7284 | 2,529.00 | ||
| Johnson & Johnson JNJ | 155.50 | 2.39 1.56% | 6,508 vs. 6,343 | 374,384.00 | 21,382.00 | 3,255.00 | 2,850.00 | 153,378.00 | 1.3500 | 29.1832 | 0.0076 | 0.6878 | 0.1522 | 0.0465 | 0.0189 | 0.8448 | 2,407.00 | ||
| Biogen Inc. BIIB | 158.01 | 2.01 1.29% | 1,736 vs. 1,296 | 23,025.00 | 2,200.00 | 393.00 | 432.00 | 18,021.00 | 2.7100 | 19.8229 | 0.0000 | 0.6865 | 0.1788 | 0.0259 | 0.0148 | 0.9539 | 145.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.